Currently predicting for Thu, 2 May 2024

Trading levels for BMY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 44.88 1.51 %
R2 44.59 0.87 %
R1 44.42 0.474 %
Current price: 44.21
Support S1 43.85 -0.81 %
S2 43.68 -1.20 %
S3 43.39 -1.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.59 16.69 %
R2 48.71 10.18 %
R1 44.70 1.11 %
Current price 44.21
Support S1 43.94 -0.611%
S2 0 .
S3 0 .

BMY Predictions History

4 years ago
NavinPerumal123283 predicted that BMY for 2019-12-10 is going

Rank:

4 years ago
2poJeff predicted that BMY for 2019-12-10 is going $60.25 (-1.68%)

4 years ago
nasser rahbi predicted that BMY for 2019-11-25 is going $56.45 (0.00%)

Rank:

4 years ago
Chaser predicted that BMY for 2019-09-16 is going $50.04 (1.23%)

4 years ago
Chaser predicted that BMY for 2019-08-12 is going $46.79 (-1.12%)

4 years ago
Chaser predicted that BMY for 2019-07-31 is going $44.99 (1.31%)

4 years ago
Chaser predicted that BMY for 2019-06-20 is going $48.84 (-0.10%)

4 years ago
JS predicted that BMY for 2019-06-17 is going $46.67 (-1.87%)

4 years ago
Chaser predicted that BMY for 2019-06-13 is going $47.97 (1.35%)

4 years ago
Chaser predicted that BMY for 2019-05-24 is going $47.78 (2.07%)

Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT